Wolff, S N <br/><br/>
High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 1983 
 - 701-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1983.1.11.701  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Blood Cell Count<br/>Bone Marrow--drug effects<br/>Bone Marrow Transplantation<br/>Combined Modality Therapy<br/>Dose-Response Relationship, Drug<br/>Drug Evaluation<br/>Drug Resistance<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Podophyllotoxin--analogs & derivatives